Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?

Archive ouverte

Roy, Jérôme | Le Guennec, Jean-Yves | Galano, Jean-Marie | Thireau, Jérôme | Bultel-Poncé, Valérie | Demion, Marie | Oger, Camille | Lee, Jetty Chung-Yung | Durand, Thierry

Edité par CCSD ; Elsevier -

International audience. Non-enzymatic oxygenated metabolites derived from polyunsaturated fatty acids (PUFA) are formed in vivo through free radical reaction under oxidative stress conditions. It has been over twenty-five years since the discovery of cyclic oxygenated metabolites derived from arachidonic acid (20:4 n-6), the isoprostanes, and since then they have become biomarkers of choice for assessing in vivo OS in humans and animals. Chemical synthesis of n-3 PUFA isoprostanoids such as F3-Isoprostanes from eicosapentaenoic acid (20:5 n-3), and F4-Neuroprostanes from docosahexaenoic acid (22:6 n-6) unravelled novel and unexpected biological properties of such omega-3 non-enzymatic cyclic metabolites as highlighted in this review.

Suggestions

Du même auteur

Non-enzymatic oxidized metabolite of DHA, 4( RS )-4-F 4t -neuroprostane protects the heart against reperfusion injury

Archive ouverte | Roy, Jérôme | CCSD

International audience. Acute myocardial infarction leads to an increase in oxidative stress and lipid peroxidation. 4(RS)-4-F4t-Neuroprostane (4-F4t-NeuroP) is a mediator produced by non-enzymatic free radical pero...

Biological activities of non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic compounds?

Archive ouverte | Galano, Jean-Marie | CCSD

International audience. ω3 Polyunsaturated fatty acids (ω3 PUFAs) have several biological properties including anti-arrhythmic effects. However, there are some evidences that it is not solely ω3 PUFAs per se that ar...

Two sides of the same coin: NEO-PUFAs in Rett syndrome and post-infarction cardiac arrhythmias

Archive ouverte | Demion, Marie | CCSD

International audience. An imbalance between oxidants and antioxidants that favors the oxidants leads to a disruption of the redox signaling control and/or molecular damage. The action of the oxidants in a non‐enzym...

Chargement des enrichissements...